AI-Driven Operational Optimization in Drug Benefit Service Quality Frameworks
Keywords:
Artificial Intelligence, Drug Benefit Management, Pharmacy Benefit Management, Service Quality FrameworksAbstract
The growing complexity of healthcare administration, prescription benefit management, medication utilization review, and patient-centered pharmaceutical services has increased the demand for intelligent operational frameworks capable of improving service quality while reducing administrative burden. Drug Benefit Service Quality Frameworks, particularly within Pharmacy Benefit Management (PBM) environments, face persistent challenges associated with claim processing accuracy, prior authorization delays, medication adherence monitoring, adverse drug event detection, data interoperability, and personalized therapeutic decision support. Recent advances in artificial intelligence (AI), machine learning, semantic knowledge systems, predictive analytics, and robotic process automation have created opportunities to transform operational processes and quality management mechanisms across pharmaceutical benefit ecosystems.
This research investigates the role of AI-driven operational optimization in enhancing Drug Benefit Service Quality Frameworks through the integration of predictive intelligence, automated decision support, semantic healthcare knowledge models, pharmacogenomic data resources, and process automation technologies. The study synthesizes existing literature on drug knowledge repositories, semantic web technologies, drug recommendation frameworks, predictive prescription systems, pharmacogenomics databases, adverse drug reaction resources, and robotic process automation in PBM quality management. A conceptual framework is developed that illustrates how AI technologies can optimize service quality dimensions including efficiency, accuracy, responsiveness, compliance, personalization, and patient safety.
The research adopts a conceptual analytical methodology supported by comparative literature synthesis. The proposed framework integrates knowledge extraction mechanisms, predictive analytics engines, automated workflow orchestration, semantic interoperability modules, and quality monitoring systems. Findings indicate that AI-enabled service quality frameworks significantly improve operational consistency, reduce manual intervention, enhance decision-making accuracy, strengthen regulatory compliance, and facilitate personalized medication management. Furthermore, robotic process automation demonstrates substantial benefits in PBM quality operations by automating repetitive administrative tasks while allowing healthcare professionals to focus on clinical decision-making and patient engagement.
The study contributes to healthcare informatics and pharmaceutical service management literature by proposing an integrated AI-driven operational optimization model specifically tailored for drug benefit service environments. The findings suggest that successful implementation requires balanced consideration of data quality, algorithm transparency, governance structures, and interoperability standards. Future research should focus on empirical validation, real-world deployment assessments, and the development of explainable AI frameworks for pharmaceutical benefit management systems.
Downloads
References
1. Ben Abacha and P. Zweigenbaum, “Medical question answering: Translating medical questions into SPARQL queries,” in Proc. 2nd ACM SIGHIT Int. Health Inform. Symp., 2012, pp. 41–50.
2. Doulaverakis et al., “Panacea, a semantic-enabled drug recommendations discovery framework, ” J. Biomed. Semant., vol. 5, 2014, Art. no. 13.
3. Knox et al., “Drugbank 3.0: A comprehensive resource for omics research on drugs, ” Nucleic Acids Res., vol. 39, no. suppl 1, pp. D1035–D1041, 2011.
4. K. Sangkuhl et al., “Pharmgkb: Understanding the effects of individual genetic variants, ” Drug Metabolism Rev., vol. 40, no. 4, pp. 539–551, 2008.
5. M. Dumontier and N. Villanueva-Rosales, “Towards pharmacogenomics knowledge discovery with the semantic web, ” Briefings Bioinform., vol. 10, no. 2, pp. 153–163, 2009.
6. M. Kanehisa and S. Goto, “Kegg: Kyoto encyclopedia of genes and genomes, ” Nucleic Acids Res., vol. 28, no. 1, pp. 27–30, 2000.
7. M. Kuhn et al., “A side effect resource to capture phenotypic effects of drugs, ” Mol. Syst. Biol., vol. 6, no. 1, 2010, Art. no. 343.
8. S. Khemmarat and L. Gao, “Supporting drug prescription via predictive and personalized query system,” in Proc. 9th Int. Conf. Pervasive Comput. Technol. Healthcare, 2015, pp. 9–16.
9. Sravan Kumar Nidiganti. (2025). Robotic Process Automation in Pharmacy Benefit Manager (PBM) Quality. The American Journal of Applied Sciences, 7(07), 93–100. https://doi.org/10.37547/tajas/Volume07Issue07-10
10. T. Fawcett, “An introduction to ROC analysis, ” Pattern Recog. Lett., vol. 27, no. 8, pp. 861–874, 2006.
11. A.Langer et al., “A text based drug query system for mobile phones, ” Int. J. Mobile Commun., vol. 12, no. 4, pp. 411–429, Jul. 2014.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Dr. Priya Sharma
This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles published in this journal are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under this license:
- Share: Copy and redistribute the material in any medium or format
- Adapt: Remix, transform, and build upon the material for any purpose, including commercially
Attribution required: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
License URL: https://creativecommons.org/licenses/by/4.0/
Authors retain copyright of their work while granting the journal first publication rights.
